Evans Blue Inhibits HBV Replication Through a Dual Antiviral Mechanism by Targeting Virus Binding and Capsid Assembly

Chronic hepatitis B (CHB) is a global health problem caused by human hepatitis B virus (HBV). Current treatment with interferons and nucleos(t)ide analogs (NAs) can cause population tolerance and drug resistance. Therefore, new antiviral drugs, especially those targeting host factors, are urgently n...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Yu, Liu, Chunlan, Tang, Wei, Zhang, Haiwei, Chen, Xulin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Microbiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868041/
https://www.ncbi.nlm.nih.gov/pubmed/31798562
http://dx.doi.org/10.3389/fmicb.2019.02638

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6868041/
https://www.ncbi.nlm.nih.gov/pubmed/31798562
http://dx.doi.org/10.3389/fmicb.2019.02638

Ejemplares similares